Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “C. Difficile Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT02395848
What this trial is testing

Efficacy of 30-day Duration of Fidaxomicin for Recurrent C. Difficile Infection

Who this might be right for
Clostridium Difficile Infection
McMaster University 31
Not applicableNot Yet RecruitingNCT07512908
What this trial is testing

Study of Factors Influencing the Dynamics of Colonisation and Decolonisation of the Digestive Tract by Clostridioides Difficile in Infants

Who this might be right for
Bacteria Infection Mechanism
Fondation Hôpital Saint-Joseph 200
Not applicableWithdrawnNCT01472978
What this trial is testing

Prospective Study of Clostridium Difficile in Children Undergoing Colonoscopy

Who this might be right for
C. Difficile Infection
State University of New York at Buffalo
Not applicableStudy completedNCT03117582
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics

Who this might be right for
Clostridium Difficile
University of North Carolina, Chapel Hill 34
Testing effectiveness (Phase 2)Study completedNCT03497806
What this trial is testing

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionRecurrent Clostridium Difficile InfectionC. Diff+8 more
Finch Research and Development LLC. 132
Early research (Phase 1)UnknownNCT02112279
What this trial is testing

Reduction of C-Difficile Infection Using Stool Transplant

Who this might be right for
C-difficile
Providence Holy Cross Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Testing effectiveness (Phase 2)Study completedNCT01680874
What this trial is testing

Probiotics for Clostridium Difficile Infection in Older Adults

Who this might be right for
Clostridium Difficile
University of Wisconsin, Madison 33
Large-scale testing (Phase 3)Ended earlyNCT03005379
What this trial is testing

Microbiota or Placebo After Antimicrobial Therapy for Recurrent C. Difficile at Home (MATCH)

Who this might be right for
Clostridium Difficile Infection
VA Office of Research and Development 153
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461
What this trial is testing

A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

Who this might be right for
Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more
PharmaPlanter Technologies Inc 63
Testing effectiveness (Phase 2)Study completedNCT01230957
What this trial is testing

Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults

Who this might be right for
Clostridium Difficile InfectionDiarrhea
Sanofi Pasteur, a Sanofi Company 650
Early research (Phase 1)Study completedNCT02830542
What this trial is testing

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Who this might be right for
Clostridium Difficile Infection
Seres Therapeutics, Inc. 96
Testing effectiveness (Phase 2)Study completedNCT01232595
What this trial is testing

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

Who this might be right for
Moderate Clostridium Difficile Infection
Novartis Pharmaceuticals 109
Early research (Phase 1)Not Yet RecruitingNCT05852587
What this trial is testing

Xylitol Use for Decolonization of C. Difficile in Patients With IBD

Who this might be right for
Inflammatory Bowel DiseasesClostridioides Difficile Infection
Brigham and Women's Hospital 99
Large-scale testing (Phase 3)Ended earlyNCT05153499
What this trial is testing

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

Who this might be right for
Recurrent C. Difficile Infection
Finch Research and Development LLC. 19
Large-scale testing (Phase 3)Active Not RecruitingNCT05330182
What this trial is testing

LMN-201 for Prevention of C. Difficile Infection Recurrence

Who this might be right for
Clostridioides Difficile Infection
Lumen Bioscience, Inc. 375
Large-scale testing (Phase 3)UnknownNCT02466698
What this trial is testing

Intestinal Lavage for the Treatment of Severe C. Difficile Infections

Who this might be right for
Clostridium Difficile
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Testing effectiveness (Phase 2)Ended earlyNCT03795233
What this trial is testing

Fecal Microbiota Transplant for Primary CDI

Who this might be right for
Clostridium Difficile Infection
Boston Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT03462459
What this trial is testing

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

Who this might be right for
Recurrent Clostridium Difficile InfectionClostridium Difficile InfectionCDI+3 more
University of Wisconsin, Madison 79
Large-scale testing (Phase 3)Looking for participantsNCT06979609
What this trial is testing

Secondary Prevention of Clostridioides Difficile Using Vancomycin

Who this might be right for
Clostridioides Difficile InfectionClostridioides Difficile Infection RecurrenceClostridoides Difficile Associated Disease
McGill University Health Centre/Research Institute of the McGill University Health Centre 300
Next Page